CUE
Cue Biopharma
25.90$
+1.4%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | +202.6% | -8.8% | +373.7% | -91.7% | +341.0% | +69.2% | +195.7% | |
| – | +350.9% | +107.6% | +6,703.2% | -3.7% | +22.0% | -105.3% | – | +2,009.4% | -93.8% | +48.1% | |
| – | – | – | – | – | -978.9% | – | -91.7% | -2,719.0% | – | +195.7% | |
| – | +278.3% | +232.3% | +51.0% | -3.7% | +22.0% | +23.3% | -6.7% | +5.8% | -11.0% | +4.0% | |
| – | +363.6% | +119.9% | +160.6% | +12.8% | +15.0% | +18.1% | -6.6% | +3.2% | -12.6% | +11.4% | |
| – | +297.1% | +203.4% | +71.5% | +1.0% | -63.6% | +300.3% | -7.1% | -64.1% | +159.9% | +6.3% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -91.8% | +273.4% | -58.8% | +74.4% | -36.1% | -55.2% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -50.1% | -49.9% | +140.0% | -143.3% | – | -1,344.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.